Analysis of Incyte Corporation (0J9P)
Based on the provided data for Incyte Corporation (symbol: 0J9P), here is a short analysis:
1. Price Movement:
- The closing prices have been fluctuating between $57.045 and $57.885 over the past few days.
- There seems to be some volatility in the stock price, with both highs and lows within a relatively narrow range.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values range from 62.77635 to 66.00702, indicating that the stock is neither oversold nor overbought.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values show positive trends, with the MACD line consistently above the signal line.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing an upward trend, suggesting a bullish sentiment.
3. Overall Analysis:
- The stock seems to be in an uptrend based on the moving averages and MACD indicator.
- The RSI values indicate that the stock is not in extreme territory, which could suggest a balanced market sentiment.
- The recent price movements show some stability, but investors should continue to monitor the stock for any significant changes.
Please note that this analysis is based on the provided data and should be supplemented with additional research before making any investment decisions.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a significant increase in sales from 2020 to 2022, followed by a slight decrease in 2023.
- Overall, there has been a positive revenue growth trend over the past four years, indicating the company's ability to generate increasing sales.
- It is important to further analyze the reasons behind the fluctuations in sales figures to understand the factors driving the company's revenue performance.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:
1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2020 at $65,339,000,000.
6. The company has been relying more on non-current assets to support its operations over the years.
7. There is a significant amount of debt in the company's capital structure, both short-term and long-term.
8. The company has been investing heavily in investments and advances as part of its non-current assets.
9. Retained earnings have been negative in some years, indicating losses or dividend payouts exceeding profits.
10. The company has been maintaining a significant amount of cash and cash equivalents over the years.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a relatively low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the stock's performance over the past year, with a beta of 1.264 and key moving averages. The company also pays dividends, with details on dividend dates, rates, and yields provided.
Valuation metrics show the company's price-to-earnings ratios, price-to-book ratio, and other key financial indicators. The enterprise value, market capitalization, and other valuation measures are also included in the data.
Overall, the data provides a comprehensive overview of the company's financial health, stock performance, valuation, and dividend policies.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This forecast suggests an increase from the EPS of $6.59 reported for the current fiscal year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, with expected growth in both the quarterly and annual results over the specified periods.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:
- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
It can be observed that the company is expected to experience a significant increase in growth rate in the next year compared to the current year. The long-term outlook also shows a positive trend with a projected 11% CAGR over the next 5 years. However, the past 5 years have seen a much higher growth rate, indicating a potential slowdown in growth in recent years.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it seems that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, it's important to note that there is a wide range of forecasts, from a low of $164 to a high of $250. The current price of $191.57 is below both the average and median forecast, indicating a potential upside according to the analysts' predictions.MACD of 0J9P